难治性淋巴瘤的药物治疗进展

被引:8
作者
卢学春
于力
机构
[1] 解放军总医院血液内分泌科
关键词
淋巴瘤,难治性; 抗体,单克隆; 放射免疫疗法;
D O I
暂无
中图分类号
R733.1 [网状内皮系统肿瘤];
学科分类号
100117 [系统生物医学];
摘要
引用
收藏
页码:1272 / 1274
页数:3
相关论文
共 3 条
[1]
High expression of nucleoside transporter protein hENT1 in Reed–Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine; vinorelbine and liposomal doxorubicin – A CALGB 59804 correlative study[J] Raymond Lai;Nancy L. Bartlett;John R. Mackey;Sin-Ho Jung;Jeffrey L. Johnson;James R. Cook;Dan Jones;Carol E. Cass;James D. Young;Jonathan Said;Bruce Cheson;Eric D. Hsi Leukemia & Lymphoma 2008,
[2]
Treatment success against stubborn lymphoid cancers[J] Kathryn Senior Lancet Oncology 2006,
[3]
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: An evidence-based review[J] Theresa Hahn;Steven N. Wolff;Myron Czuczman;Richard I. Fisher;Hillard M. Lazarus;Julie Vose;Lisa Warren;Richard Watt;Philip L. McCartby Biology of Blood and Marrow Transplantation 2001,